If you need more lookups,
subscriptions start at $34 USD/month.
Anders Hinsby Location
Copenhagen, DK
Anders Hinsby Work
Chief Operating Officer @ (June 2021 - Present)
Co-founder and Chief Executive Officer @ (May 2020 - June 2021)
Independent Director @ (August 2020 - Present)
Chairman of the Board @ (June 2022 - Present)
Entrepreneur in Residence @ (February 2020 - Present)
Member Board Of Directors @ (September 2019 - April 2022)
Member Board of Directors @ (June 2015 - Present)
Co-Founder and Chief Executive Officer @ (June 2020 - July 2021)
Chief Executive Officer @ (January 2010 - September 2019)
Partner @ (January 2009 - January 2010)
Director in the Board of Directors @ F2g Santaris Pharma and Juvantia (August 2008 - January 2010)
Co-Founder @ Orphazyme Aps (June 2009 - June 2009)
Principal and Associate @ (October 2006 - December 2008)
Ipr Consultant @ (January 2005 - January 2006)
Assistant Professor in Bioinformatics and Systems Biology @ (January 2004 - January 2005)
Scientific Analyst @ (January 2003 - January 2004)
ph.d. Medicine @ MDS Proteomics/U of Copenhagen (January 2001 - January 2004)
Anders Hinsby Education
Københavns Universitet
Doctor of Philosophy (Biology, Medicine)
Anders Hinsby Skills
Biotechnology
Proteomics
Lifesciences
Intellectual Property
Pharmaceutical Industry
Clinical Development
Molecular Biology
Drug Discovery
Drug Development
Immunology
Biopharmaceuticals
Anders Hinsby Summary
Anders Hinsby, based in Copenhagen, DK, is currently a Chief Operating Officer at Muna Therapeutics. Anders Hinsby brings experience from previous roles at Muna Therapeutics, Vico Therapeutics B.V., Pephexia Therapeutics ApS and BiOrigin. Anders Hinsby holds a Doctor of Philosophy in Biology, Medicine @ Københavns Universitet. With a robust skill set that includes Biotechnology, Proteomics, Lifesciences, Intellectual Property, Pharmaceutical Industry and more. Anders Hinsby has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Anders Hinsby?
Find contact details for 700 million professionals.